Clinical Trial Update: A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a single-arm, open-label Phase I/II study of GFH276 in patients with RAS-mutant advanced solid tumors, currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• GFH276

Snippet

Sponsor: Genfleet Therapeutics (Shanghai) Inc. | Conditions: Cancer, PDAC | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING